Search 33,000+ CME courses
Back

PRIME Education, Inc. (PRIME®)

  • Antibodies, Bispecific
  • Cytokine Release Syndrome

Managing the Storm: Taming CRS in the Era of Bispecific Antibodies

With the growing use of bispecific antibodies (BsAbs) in the treatment of non-Hodgkin lymphoma (NHL), timely recognition and management of cytokine release syndrome (CRS) is essential to ensuring safe and effective patient care. This interactive, case-based simulation immerses hematology/oncology care teams in realistic clinical scenarios that challenge them to identify, assess, and manage CRS with confidence. Learners will engage in a collaborative experience centered on navigating complex decision-making moments around CRS identification, severity assessment, and multidisciplinary care strategies. Through practical application and expert guidance, participants will sharpen their skills in real-time decision-making and walk away with actionable strategies to optimize outcomes for patients receiving BsAb therapy. Join us and prepare your team for the complexities of CRS, before it becomes a crisis.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.25 creditsAAPA Category 1 Credit™Up to 0.25 creditsAMA PRA Category 1 Credit™Up to 0.25 creditsNursingUp to 0.25 creditsPharmacyUp to 0.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Free

Reported to ACCME by the provider

  • Case-based learning
  • Credit · Up to 0.25 credits
  • Commercial Support
  • Released
    Nov 26, 2025
  • Last day to claim credit
    Nov 26, 2026 7 weeks left

Related courses

See all

Other providers’ courses on the same topic

More from PRIME Education, Inc. (PRIME®)

See all

This provider’s courses closest to this one